Concepedia

Fengfeng Xie

FX

Statistics

Publications

6

Citations

210

H-Index

6

Active since

2015

Affiliations

First Affiliated Hospital of Wenzhou Medical University(Current)

Wenzhou Medical University

Jinan University

Fengfeng Xie is an author at First Affiliated Hospital of Wenzhou Medical University specializing in pharmacology, oncology, and medicine.

Publications per year

2015–2022

6

Publications

6

Sequential combination therapy of ovarian cancer with cisplatin and γ-secretase inhibitor MK-0752

Xiuxiu Chen, Li-Hua Gong, Rongying Ou et al. · Gynecologic Oncology · 2015 · 70 citations

, , +15

Cyclin-dependent kinase inhibitor dinaciclib potently synergizes with cisplatin in preclinical models of ovarian cancer

Xiuxiu Chen, Fengfeng Xie, Xiu-Jie Zhu et al. · Oncotarget · 2015 · 61 citations · Full text

, , +17

Berberine Ameliorates Insulin Resistance by Inhibiting IKK/NF-κB, JNK, and IRS-1/AKT Signaling Pathway in Liver of Gestational Diabetes Mellitus Rats

Anyang Li, Lin Cong, Fengfeng Xie et al. · Metabolic Syndrome and Related Disorders · 2022 · 25 citations

, , +16

Volasertib suppresses tumor growth and potentiates the activity of cisplatin in cervical cancer.

Fengfeng Xie, Shi-Shi Pan, Rongying Ou et al. · PubMed · 2015 · 22 citations

, , +17

Crizotinib synergizes with cisplatin in preclinical models of ovarian cancer.

Xiaoxiu Huang, Fengfeng Xie, Li-Jiao Hou et al. · PubMed · 2017 · 21 citations

, , +17

1–5 of 6